Published in Neurobiol Aging on November 23, 2005
Self-reported memory complaints: implications from a longitudinal cohort with autopsies. Neurology (2014) 2.66
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement (2014) 2.46
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia (2012) 1.90
Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol (2012) 1.64
Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. Cereb Cortex (2007) 1.33
In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI. J Alzheimers Dis (2012) 1.30
Altered default mode network connectivity in older adults with cognitive complaints and amnestic mild cognitive impairment. J Alzheimers Dis (2013) 1.21
Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiol Aging (2008) 1.05
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. J Alzheimers Dis (2015) 1.04
Increased functional connectivity and brain atrophy in elderly with subjective memory complaints. Brain Connect (2013) 1.01
Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders. Neurobiol Aging (2010) 0.98
Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument. JAMA Neurol (2015) 0.95
Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol Aging (2011) 0.94
Memory loss in Alzheimer's disease. Dialogues Clin Neurosci (2013) 0.94
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimers Dement (2015) 0.91
Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease. Neurobiol Aging (2010) 0.89
Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis. Front Cell Neurosci (2014) 0.89
The Memory and Aging Telephone Screen: development and preliminary validation. Alzheimers Dement (2007) 0.89
Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer's disease. Brain Imaging Behav (2015) 0.89
Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimers Dement (Amst) (2015) 0.88
Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders. J Alzheimers Dis (2015) 0.85
Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study. J Alzheimers Dis (2015) 0.85
Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly. Neurology (2015) 0.85
Subjective cognitive concerns, episodic memory, and the APOE ε4 allele. Alzheimers Dement (2014) 0.84
Early dysfunction of functional connectivity in healthy elderly with subjective memory complaints. Age (Dordr) (2011) 0.83
BDNF val66met polymorphism affects aging of multiple types of memory. Brain Res (2014) 0.83
Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD. Alzheimers Dement (Amst) (2015) 0.81
The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests. J Alzheimers Dis (2016) 0.81
Development of a subjective cognitive decline questionnaire using item response theory: a pilot study. Alzheimers Dement (Amst) (2015) 0.80
Age-related changes in the mesial temporal lobe: the parahippocampal white matter region. Neurobiol Aging (2011) 0.78
Parahippocampal white matter volume predicts Alzheimer's disease risk in cognitively normal old adults. Neurobiol Aging (2014) 0.78
White matter degeneration in subjective cognitive decline: a diffusion tensor imaging study. Oncotarget (2016) 0.78
Structural neuroimaging of concomitant depressive symptoms in amnestic mild cognitive impairment: a pilot study. Dement Geriatr Cogn Dis Extra (2012) 0.77
Non-Alzheimer's disease-related memory impairment and dementia. Dialogues Clin Neurosci (2013) 0.77
Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment. J Alzheimers Dis (2015) 0.77
A 'Disease Severity Index' to identify individuals with Subjective Memory Decline who will progress to mild cognitive impairment or dementia. Sci Rep (2017) 0.76
Differential association of left and right hippocampal volumes with verbal episodic and spatial memory in older adults. Neuropsychologia (2016) 0.76
A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease. J Mol Neurosci (2016) 0.76
Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study. Sci Rep (2016) 0.75
Subjective word-finding difficulty reduces engagement in social leisure activities in Alzheimer's disease. J Am Geriatr Soc (2014) 0.75
The association between subjective memory complaint and objective cognitive function in older people with previous major depression. PLoS One (2017) 0.75
The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders. J Neural Transm (Vienna) (2014) 0.75
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ (2003) 3.78
Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. Am J Hum Genet (2006) 3.67
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci (2010) 3.12
Genome-wide association study of alcohol dependence. Arch Gen Psychiatry (2009) 3.08
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry (2005) 2.84
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
Descending necrotizing mediastinitis: contemporary trends in etiology, diagnosis, management, and outcome. Ann Surg (2010) 2.57
Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet (2010) 2.46
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry (2014) 2.43
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry (2010) 2.41
Current state and perspectives of fungal DNA barcoding and rapid identification procedures. Appl Microbiol Biotechnol (2010) 2.24
Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry (2004) 2.12
Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry (2010) 2.04
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet (2002) 1.99
Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology (2012) 1.94
Minds made for sharing: initiating joint attention recruits reward-related neurocircuitry. J Cogn Neurosci (2010) 1.89
Do schizoaffective disorders exist at all? Acta Psychiatr Scand (2006) 1.79
Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep (2013) 1.67
Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment. Eur Arch Otorhinolaryngol (2008) 1.61
Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord (2007) 1.59
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol (2011) 1.59
No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science (2002) 1.57
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. J Alzheimers Dis (2009) 1.49
The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans. Int J Neuropsychopharmacol (2008) 1.48
Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front Neuroendocrinol (2011) 1.47
Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci U S A (2003) 1.46
Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thromb Res (2010) 1.44
A genomewide linkage study on suicidality in major depressive disorder confirms evidence for linkage to 2p12. Am J Med Genet B Neuropsychiatr Genet (2010) 1.44
Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull (2008) 1.44
The German MultiCare-study: Patterns of multimorbidity in primary health care - protocol of a prospective cohort study. BMC Health Serv Res (2009) 1.43
A genome-wide significant linkage for severe depression on chromosome 3: the depression network study. Am J Psychiatry (2011) 1.41
Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry (2010) 1.39
Prediction of psychosis by mismatch negativity. Biol Psychiatry (2010) 1.38
Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry (2011) 1.36
Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J (2009) 1.35
Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci (2004) 1.34
Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res (2014) 1.32
The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry (2005) 1.31
Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry (2008) 1.31
Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry (2005) 1.30
Noradrenergic modulation of emotion-induced forgetting and remembering. J Neurosci (2005) 1.29
Executive performance of depressed suicide attempters: the role of suicidal ideation. Eur Arch Psychiatry Clin Neurosci (2008) 1.27
Oxytocin modulates social distance between males and females. J Neurosci (2012) 1.26
Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry (2005) 1.26
The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet (2003) 1.26
Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002-2007. Dement Geriatr Cogn Disord (2008) 1.26
Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet (2005) 1.25
Prediction of dementia in primary care patients. PLoS One (2011) 1.25
Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J Neurol Neurosurg Psychiatry (2007) 1.25
Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry (2009) 1.25
Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res (2012) 1.24
Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging (2008) 1.24
Fear processing and social networking in the absence of a functional amygdala. Biol Psychiatry (2012) 1.23
Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry (2005) 1.21
Oxytocin facilitates protective responses to aversive social stimuli in males. Proc Natl Acad Sci U S A (2012) 1.21
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry (2007) 1.19
AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur J Hum Genet (2006) 1.19
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLoS Med (2012) 1.19
Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci (2014) 1.18
Paleontological and developmental evidence resolve the homology and dual embryonic origin of a mammalian skull bone, the interparietal. Proc Natl Acad Sci U S A (2012) 1.17
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry (2010) 1.16
Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med (2007) 1.16
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol (2004) 1.16
Oxytocin enhances brain reward system responses in men viewing the face of their female partner. Proc Natl Acad Sci U S A (2013) 1.15
Utilization patterns of ambulatory medical care before and after the diagnosis of dementia in Germany--results of a case-control study. Dement Geriatr Cogn Disord (2010) 1.14
The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci (2011) 1.14
Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry (2008) 1.14
Association of SORL1 gene variants with Alzheimer's disease. Brain Res (2009) 1.14
Clinical features of paraganglioma syndromes. Skull Base (2009) 1.13
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry (2009) 1.13
Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl) (2006) 1.12
Adverse reactions to antidepressants. Br J Psychiatry (2009) 1.12
Solitary neurofibroma of the maxillary sinus and pterygopalatine fossa. Otolaryngol Head Neck Surg (2005) 1.12
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophr Bull (2010) 1.10
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry (2010) 1.10
Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol (2008) 1.10
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res (2005) 1.09
Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease--a VBM study. Int J Geriatr Psychiatry (2008) 1.09
Relative impact of multimorbid chronic conditions on health-related quality of life--results from the MultiCare Cohort Study. PLoS One (2013) 1.09
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord (2009) 1.08
Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biol Psychiatry (2005) 1.08
Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci (2013) 1.07
Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry (2003) 1.07